Longeveron Inc - Tradeable Rights - August 2023
LGVNR
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.45M
Close$
Share Statistics
| Market cap | $20.45 Million |
|---|---|
| Enterprise Value | $10.99 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -225.67% |
|---|---|
| Return on Assets | -151.57% |
| Return on Invested Capital | -212.46% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 9.26 |
| Enterprise Value to EBIT | -0.46 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Longeveron Inc
26 employeeslongeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as...